[Federal Register Volume 61, Number 248 (Tuesday, December 24, 1996)]
[Notices]
[Page 67851]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-32610]


-----------------------------------------------------------------------


DEPARTMENT OF JUSTICE

Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated August 21, 1996, and published in the Federal 
Register on August 30, 1996, (61 FR 45986), Ciba-Geigy Corporation, 
Pharmaceuticals Division, Regulatory Compliance, 556 Morris Avenue, 
Summit, New Jersey 07901, made application by renewal to the Drug 
Enforcement Administration (DEA) to be registered as a bulk 
manufacturer by methylphenidate (1724), a basic class of controlled 
substance listed in Schedule II.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of Ciba-Geigy Corporation to 
manufacture methylphenidate is consistent with the public interest at 
this time. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 
0.104, the Deputy Assistant Administrator, Office of Diversion Control, 
hereby orders that the application submitted by the above firm for 
registration as a bulk manufacturer of the basic class of controlled 
substance listed above is granted.

    Dated: November 19, 1996.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 96-32610 Filed 12-23-96; 8:45 am]
BILLING CODE 4410-09-M